Those who have taken Covishield and Covaxin can take the nasal vaccine as a heterologous booster dose.
India’s Omicron cases tally has crossed the 700 mark leading to fresh restrictions in multiple states and union territories. Currently,…
The National Technical Advisory Group on Immunisation in India (NTAGI) is slated to meet in the coming two weeks…
More than 136 crore COVID-19 vaccine doses are expected to be available till the end of this year, informed the…
Hyderabad-based Bharat Biotech on Saturday concluded a final analysis for its vaccine Covaxin efficacy from phase-3 clinical trial claiming it…
Bharat Biotech's Covaxin has shown 77.8 per cent efficacy after the Subject Expert Committee (SEC) under the drug regulator reviewed…
Indigenous COVID-19 vaccine maker Bharat Biotech on Tuesday said the supply price of Covaxin to the Government of India at…
The screening of children aged 6 to 12 years for the clinical trials of indigenously developed Covid-19 vaccine, Bharat Biotech's…
Bharat Biotech on Saturday shared full data of all research studies of its Covaxin - India's first indigenous COVID-19 vaccine.…
The Union Health Ministry on Tuesday informed that the Centre has placed an order to purchase 25 crores doses of…